Top

Notification of interruption to supply

20 March 2017

RANZCOG has been notified by Pfizer that due to manufacturing issues, the current stock of PROSTIN® E2 VAGINAL GEL 2mg is expected to be depleted by the end of March 2017, and availability of new stock is not expected until May 2017. There is no safety concern with this medicine.
 
Vaginal dinoprostone is available from another manufacturer.
 
Full Product Information for PROSTIN® E2 VAGINAL GEL can be accessed at www.pfizer.com.au
 
For any medical enquiries regarding PROSTIN® E2 VAGINAL, contact Pfizer Medical Information on 1800 675 229.
 
As RANZCOG recognises the potential impact this may have on your practice, to hospital departments across Australia, and to the women in your care, we are endeavouring to ensure all members are made aware of this important issue through multiple communication channels.


 



MEDIA CENTRE

News

International Pregnancy and Infant Loss Remembrance Day 2021

The members of RANZCOG acknowledge the parents and families who have experienced pregnancy and infant loss.

15/10/2021

News

Updated College Statements

These statements have been reviewed and updated during the March and July Council sessions, and published on the RANZCOG website.

08/10/2021

News

2021 RANZCOG Wellbeing Awards - Nomination Summaries

Congratulations to all who were nominated in our inaugural Wellbeing Awards.

08/10/2021